XOMA Royalty Long Term Deferred Assets (Quarterly) Insights

XOMA Royalty Corp. (XOMA)

25.89 -0.48 (-1.82%) USD | NASDAQ | Jan 20, 09:37

View Long Term Deferred Assets (Quarterly) for XOMA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

Mirum Pharmaceuticals, Inc.	--
Recursion Pharmaceuticals, Inc.	Upgrade
Rezolute, Inc.	--
Vistagen Therapeutics, Inc.	--
Zevra Therapeutics, Inc.	--